Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to cut hospital visits by helping cancer patients speak up

NCT ID NCT07278739

Recruiting now Symptom relief Sponsor: SWOG Cancer Research Network Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 06, 2026 · Updated 5 times

Summary

This trial tests an educational program called A-PACT for people with solid tumors who are at high risk of decline. Trained lay health workers coach patients on how to discuss their care goals and end-of-life wishes with their medical team. The study will see if this reduces unplanned hospital stays and improves communication. About 1,020 participants will be randomly assigned to receive A-PACT or usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Educational program (A-PACT) with lay health worker coaching
What this could lead to
If it works, this program could help cancer patients have better conversations with their doctors about what matters most, potentially reducing stressful hospital visits.
What could go wrong
This is a behavioral intervention, not a drug; its benefits depend on patient engagement and may not change hard outcomes like survival. The trial is not yet recruiting, so results are years away.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

  • CARTI Cancer Center

    RECRUITING

    Little Rock, Arkansas, 72205, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.